Clinical trial
Phase I Protocol for the Evaluation of the Safety and Immunogenicity of…
NCT00001386 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001386 |
|---|---|
| Title | Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection |
| Official title | Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Acquired Immunodeficiency Syndrome, HIV Infection |
| Intervention type | Drug |
| Interventions | PCLUS 3-18 MN, PCLUS 6.1 MN |
| Enrollment | 31 |
| Start date | Jun 1, 1994 |
| Completion | Jan 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: